Home > Healthcare > Analytical Instruments > Molecular Analysis > Bioprocess Analyzers Market

Bioprocess Analyzers Market Trends

  • Report ID: GMI8765
  • Published Date: Mar 2024
  • Report Format: PDF

Bioprocess Analyzers Market Trends

The growing demand for biopharmaceutical products plays a pivotal role in the market. Biopharmaceutical products, such as monoclonal antibodies, vaccines, and recombinant proteins, are often produced through complex bioprocesses involving living cells.
 

  • For instance, according to the Pharmaceutical Research and Manufacturers of America, in 2023, the world witnessed the administration of more than 20 billion COVID-19 vaccine doses, surpassing the World Health Organization's (WHO) goal of vaccinating 70% of the population.
     
  • The quality of biopharmaceuticals is paramount, as deviations in bioprocessing conditions can impact product purity, efficacy, and safety. Bioprocess analyzers provide real-time data on critical parameters, ensuring that production processes remain within specified quality standards.
     
  • Bioprocess analyzers enable data-driven decisions to optimize bioreactor conditions, nutrient feeding, and cell culture growth, thereby enhancing efficiency and productivity. Consequently, biopharmaceutical manufacturers strive to maximize yields while minimizing production time and costs.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The Global bioprocess analyzers industry was valued at around USD 2.1 billion in 2023 and is estimated to reach over USD 6.9 billion by 2032, driven by advancements in biotechnology and bioprocessing, along with surge in biologics outsourcing.

Consumables & accessories segment held a decent market share in 2023 and is estimated to account for USD 3.9 billion by 2032, as these items are consumed regularly during bioprocess monitoring, necessitating frequent replenishment.

North America bioprocess analyzers market accounted for USD 831.4 million in 2023 and is predicted to witness substantial growth through 2032, driven by a well-established and thriving biopharmaceutical sector in the region.

Agilent Technologies, Inc., Algenax, Danaher Corporation, F. Hoffmann-La Roche Ltd, Groton Biosystems LLC, Kaiser Optical Systems, Inc., Nova Biomedical, Randox Laboratories Ltd., Sartorius AG, SYSBIOTECH GmbH, Thermo Fisher Scientific Inc. are some of the major industry contenders.

Bioprocess Analyzers Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 272
  • Countries covered: 22
  • Pages: 150
 Download Free Sample